Form 4 for LUCYW Innovative Eyewear Inc
Accepted 2024-09-24 00:00:00 ET · period of report 2024-09-19 · accession 0001376474-24-000535 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-09-24 | 2024-09-19 | LUCYW | Galkin Vladimir | 10% | P - Purchase | $8.91 | +297.4K | 722.7K | +70% | +$2.65M |
| MI | 2024-09-24 | 2024-09-19 | LUCYW | Galkin Vladimir | 10% | S - Sale | $9.07 | -42.3K | 744.1K | -5% | -$384.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 | 2024-09-19 | P | A | 37,195 | $8.10 | 785,573 | I See footnote | — | — | (F6) The purchases were executed in multiple trades at prices ranging from $8.10 to $8.27. (F1) The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4. (F3) The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose. |
| 2 | Common | Common Stock, par value $0.00001 | 2024-09-19 | S | D | 901 | $8.50 | 743,245 | I See footnote | — | — | (F1) The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4. (F10) The sales were executed in multiple trades at a price of $8.50. (F3) The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose. |
| 3 | Common | Common Stock, par value $0.00001 | 2024-09-19 | P | A | 124,562 | $9.15 | 612,692 | I See footnote | — | — | (F2) The purchases were executed in multiple trades at prices ranging from $9.01 to $9.20. (F1) The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4. (F3) The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose. |
| 4 | Common | Common Stock, par value $0.00001 | 2024-09-19 | S | D | 780 | $9.79 | 784,793 | I See footnote | — | — | (F7) The sales were executed in multiple trades at a price of $9.79. (F1) The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4. (F3) The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose. |
| 5 | Common | Common Stock, par value $0.00001 | 2024-09-19 | S | D | 16,223 | $9.50 | 768,570 | I See footnote | — | — | (F1) The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4. (F8) The sales were executed in multiple trades at a price of $9.50. (F3) The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose. |
| 6 | Common | Common Stock, par value $0.00001 | 2024-09-19 | S | D | 24,424 | $8.79 | 744,146 | I See footnote | — | — | (F9) The sales were executed in multiple trades at a price of $8.79. (F1) The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4. (F3) The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose. |
| 7 | Common | Common Stock, par value $0.00001 | 2024-09-19 | P | A | 25,648 | $8.62 | 748,378 | I See footnote | — | — | (F1) The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4. (F5) The purchases were executed in multiple trades at prices ranging from $8.51 to $8.75. (F3) The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose. |
| 8 | Common | Common Stock, par value $0.00001 | 2024-09-19 | P | A | 110,038 | $8.97 | 722,730 | I See footnote | — | — | (F4) The purchases were executed in multiple trades at prices ranging from $8.76 to $9.00. (F1) The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4. (F3) The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose. |